Fidelity Investments
FENC icon

Fidelity Investments’s Fennec Pharmaceuticals FENC Stock Holding History

Fidelity Investments’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.3K Buy
5,793
+1,539
+36% +$12.6K ﹤0.01% 4217
2026
Q1 		$26.2K Buy
4,254
+1,831
+76% +$14.1K ﹤0.01% 4409
2025
Q4 		$18.7K Sell
2,423
-301
-11% -$2.47K ﹤0.01% 4490
2025
Q3 		$25.5K Buy
2,724
+343
+14% +$2.97K ﹤0.01% 4263
2025
Q2 		$19.8K Buy
2,381
+540
+29% +$3.69K ﹤0.01% 4287
2025
Q1 		$11.2K Sell
1,841
-199
-10% -$1.28K ﹤0.01% 4458
2024
Q4 		$12.9K Buy
2,040
+857
+72% +$4.39K ﹤0.01% 4366
2024
Q3 		$5.92K Buy
1,183
+41
+4% +$237 ﹤0.01% 4581
2024
Q2 		$6.98K Sell
1,142
-3,911
-77% -$32.5K ﹤0.01% 4448
2024
Q1 		$56.2K Buy
5,053
+24
+0.5% +$241 ﹤0.01% 3528
2023
Q4 		$56.4K Buy
5,029
+4,607
+1,092% +$38.2K ﹤0.01% 3466
2023
Q3 		$3.17K Buy
422
+291
+222% +$2.37K ﹤0.01% 4435
2023
Q2 		$1.16K Buy
131
+19
+17% +$158 ﹤0.01% 4687
2023
Q1 		$932 Hold
112
– – ﹤0.01% 4745
2022
Q4 		$1.08K Hold
112
– – ﹤0.01% 4637
2022
Q3 		$1K Hold
112
– – ﹤0.01% 4662
2022
Q2 		$1K Hold
112
– – ﹤0.01% 4709
2022
Q1 		$1K Buy
+112
New +$564 ﹤0.01% 4786

Other funds holding FENC

Rosalind Advisors
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Solas Capital Management
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCA
Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Fidelity Investments's FENC Position: Q2 2026 in Review

Fidelity Investments increased its Fennec Pharmaceuticals (FENC) stake by 36% in Q2 2026, buying an estimated $12.6K and bringing the position to 5,793 shares worth $62.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4217.

Fidelity Investments first reported a position in FENC in Q1 2022 and has held it in 18 quarters since. 105 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • Fidelity Investments held 5,793 shares of Fennec Pharmaceuticals worth $62.3K as of Q2 2026.
  • Fidelity Investments bought 1,539 Fennec Pharmaceuticals shares in Q2 2026, an estimated $12.6K.
  • Fennec Pharmaceuticals made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #4217 holding.
  • Fidelity Investments first reported a position in Fennec Pharmaceuticals in Q1 2022 and has held it in 18 quarters since.
  • 105 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.